We believe that there are several stocks in the healthcare sector that are better than Abbott Labs. Abbott’s current market cap-to-operating income ratio of 41x compares with 12x for Emergent Biosolutions, 19x for Vertex Pharmaceuticals, and 22x for Corcept Therapeutics. Does this gap in valuation.